Exscientia Ltd ADR Performance
EXAIDelisted Stock | USD 4.84 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.29, which means not very significant fluctuations relative to the market. As returns on the market increase, Exscientia's returns are expected to increase less than the market. However, during the bear market, the loss of holding Exscientia is expected to be smaller as well. At this point, Exscientia ADR has a negative expected return of -0.16%. Please make sure to confirm Exscientia's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Exscientia ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Exscientia Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
1 | Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024 | 10/09/2024 |
2 | Exscientia to receive 15M in milestones for Sanofi collaboration | 10/16/2024 |
3 | Exscientia erreicht Meilensteine fr zwei Programme im Rahmen der Zusammenarbeit mit Sanofi | 10/17/2024 |
4 | Exscientia Stock Price Down 5.3 percent Heres Why | 11/15/2024 |
Begin Period Cash Flow | 404.6 M |
Exscientia |
Exscientia Relative Risk vs. Return Landscape
If you would invest 555.00 in Exscientia Ltd ADR on August 28, 2024 and sell it today you would lose (71.00) from holding Exscientia Ltd ADR or give up 12.79% of portfolio value over 90 days. Exscientia Ltd ADR is currently does not generate positive expected returns and assumes 3.6759% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than Exscientia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Exscientia Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Exscientia's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Exscientia Ltd ADR, and traders can use it to determine the average amount a Exscientia's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0425
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | EXAI |
Estimated Market Risk
3.68 actual daily | 32 68% of assets are more volatile |
Expected Return
-0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Exscientia is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Exscientia by adding Exscientia to a well-diversified portfolio.
Exscientia Fundamentals Growth
Exscientia Stock prices reflect investors' perceptions of the future prospects and financial health of Exscientia, and Exscientia fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Exscientia Stock performance.
Return On Equity | -0.46 | ||||
Return On Asset | -0.21 | ||||
Operating Margin | (10.66) % | ||||
Current Valuation | 346.92 M | ||||
Shares Outstanding | 130.82 M | ||||
Price To Book | 1.95 X | ||||
Price To Sales | 37.10 X | ||||
Revenue | 20.08 M | ||||
EBITDA | (145.45 M) | ||||
Cash And Equivalents | 601.89 M | ||||
Cash Per Share | 4.91 X | ||||
Total Debt | 18.92 M | ||||
Debt To Equity | 0.01 % | ||||
Book Value Per Share | 1.95 X | ||||
Cash Flow From Operations | (117.6 M) | ||||
Earnings Per Share | (1.51) X | ||||
Total Asset | 510.72 M | ||||
Retained Earnings | (110.47 M) | ||||
About Exscientia Performance
By evaluating Exscientia's fundamental ratios, stakeholders can gain valuable insights into Exscientia's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Exscientia has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Exscientia has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom. Exscientia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people.Things to note about Exscientia ADR performance evaluation
Checking the ongoing alerts about Exscientia for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Exscientia ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Exscientia ADR generated a negative expected return over the last 90 days | |
Exscientia ADR has high historical volatility and very poor performance | |
Exscientia ADR has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 20.08 M. Net Loss for the year was (145.96 M) with profit before overhead, payroll, taxes, and interest of 10.25 M. | |
Exscientia Ltd ADR currently holds about 601.89 M in cash with (117.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.91, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
Roughly 26.0% of the company shares are held by company insiders | |
Latest headline from thelincolnianonline.com: Exscientia Stock Price Down 5.3 percent Heres Why |
- Analyzing Exscientia's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Exscientia's stock is overvalued or undervalued compared to its peers.
- Examining Exscientia's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Exscientia's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Exscientia's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Exscientia's stock. These opinions can provide insight into Exscientia's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exscientia Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Exscientia Stock
If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |